FGD has been described as a syndrome secondary to ACTH resistance, and inactivating mutations in the gene encoding melanocortin type 2 receptor (MC2R) were the first to be associated with FGD [6]. Here, POMC is linked to Aarskog-Scott syndrome, X-linked.